MIR621 (microRNA 621)

2016-08-01  

Identity

HGNC
LOCATION
13q14.11
LOCUSID
ALIAS
MIRN621,hsa-mir-621

Other Information

Locus ID:

NCBI: 693206
HGNC: 32877
Ensembl: ENSG00000207652
miRBase:

Variants:

dbSNP: 693206
ClinVar: 693206
TCGA: ENSG00000207652
COSMIC: MIR621

RNA/Proteins

Expression (GTEx)

0
5
10
15

References

Pubmed IDYearTitleCitations
360877402022MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling.7
360877402022MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling.7
336295782021MiRNA-621 exerts tumor suppressor function in gastric adenocarcinoma by targeting AURKA/GSK-3β pathway.0
342451112021Hsa-circ_0000064 accelerates the malignant progression of gastric cancer via sponging microRNA-621.2
336295782021MiRNA-621 exerts tumor suppressor function in gastric adenocarcinoma by targeting AURKA/GSK-3β pathway.0
342451112021Hsa-circ_0000064 accelerates the malignant progression of gastric cancer via sponging microRNA-621.2
312103122019MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.7
317996632019LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.10
312103122019MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.7
317996632019LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.10
258670612016MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.59
258670612016MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.59

Citation

Dessen P

MIR621 (microRNA 621)

Atlas Genet Cytogenet Oncol Haematol. 2016-08-01

Online version: http://atlasgeneticsoncology.org/gene/55868/mir621-(microrna-621)